ReviewClinical journal of the American Society of Nephrology : CJASN2010
Assessment of renal pathology and dysfunction in children with Fabry disease.
Review in Clinical journal of the American Society of Nephrology : CJASN, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02994303 (Podocyturia, a Non-Invasive Predictor of Renal Dysfunction in Fabry Nephropathy), which is not on this map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Podocyturia, a Non-Invasive Predictor of Renal Dysfunction in Fabry Nephropathy
Who cites it
22 citing papers in PubMed, 44 citations in OpenAlex.
- Phenotypic Variability of Kidney Involvement in Fabry Disease-Lessons from a Family Study.Life (Basel, Switzerland) · 2026Article
- Expert Opinion on the Conceptual, Clinical, and Therapeutic Aspects of Fabry Nephropathy: A Nephrologists' Perspective.Kidney & blood pressure research · 2026Review
- Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease.Orphanet journal of rare diseases · 2024Article
- Concurrent fabry disease and immunoglobulin a nephropathy: a case report.BMC nephrology · 2023Article
- The evolution of the initial manifestations and renal involvement of chinese patients with classical and late-onset Fabry disease at different sexes and ages.BMC nephrology · 2023Article
- Clinical features and enzyme replacement therapy in 10 children with Fabry disease.Frontiers in pediatrics · 2023Article
- Expert opinion on the recognition, diagnosis and management of children and adults with Fabry disease: a multidisciplinary Turkey perspective.Orphanet journal of rare diseases · 2022Review
- Clinical Characteristics, Renal Involvement, and Therapeutic Options of Pediatric Patients With Fabry Disease.Frontiers in pediatrics · 2022Review
- Fabry disease and kidney involvement: starting from childhood to understand the future.Pediatric nephrology (Berlin, Germany) · 2022Review
- Interstitial lung disease in lysosomal storage disorders.European respiratory review : an official journal of the European Respiratory Society · 2021Article
- Fabry disease-what cardiologists can learn from the nephrologist: a narrative review.Cardiovascular diagnosis and therapy · 2021Review
- Review
- Clinical parameters, LysoGb3, podocyturia, and kidney biopsy in children with Fabry disease: is a correlation possible?Pediatric nephrology (Berlin, Germany) · 2018Article
- The renal biopsy in the genomic era.Pediatric nephrology (Berlin, Germany) · 2013Review
- Agalsidase benefits renal histology in young patients with Fabry disease.Journal of the American Society of Nephrology : JASN · 2013Article
- Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene.Clinical kidney journal · 2012Article
- Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.BMC neurology · 2011Review
- Awareness of Fabry disease among rheumatologists--current status and perspectives.Clinical rheumatology · 2011Article
- Update on role of agalsidase alfa in management of Fabry disease.Drug design, development and therapy · 2011Review
- Clinical practice: proteinuria.European journal of pediatrics · 2011Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 4 countries.
Funding
Abstract
Overt renal disease often first presents in male individuals with Fabry disease in early to middle adulthood, but proteinuria and reduced GFR may occur in adolescents and in young children. More recently, kidney biopsy data have shown early renal histologic changes in pediatric patients, and kidney dysfunction, primarily proteinuria, seems to be more common in girls. Renal investigations and their timing in children remain poorly defined. A consensus on renal investigations is necessary to understand the natural progression of the disease and to evaluate the efficacy of treatments such as enzyme replacement therapies. This article addresses three main categories: Use of GFRs, measuring albuminuria, and renal biopsies in children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.